Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.
Faster global financial news!
Changchun High-Tech: Application for Market Approval of Subsidiary’s Melatonin Granules Accepted
07/01/2026 19:28
Complaint Report
Complaint Report
Changchun High-Tech announced that recently, its controlling subsidiary, Changchun Jinsai Pharmaceutical Co., Ltd., received a "Notice of Acceptance" issued by the National Medical Products Administration, confirming that the application for domestic production and marketing authorization of Jinsai Pharmaceutical’s melatonin granules has been accepted.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice. If you find any violations, please Click to Report
Previous: Venezuela's oil reserves may be overstated; Rystad Energy believes the best estimate is 60 billion barrels
|
Minutes of the Swiss National Bank Meeting: The Committee and alternate members discussed recent developments at companies active in the U.S. artificial intelligence sector. They discussed the high valuations of these companies with experts.: Next
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
Scan to Download App
